Nuvation Bio Stock Alpha and Beta Analysis
| NUVB Stock | USD 2.14 0.07 3.17% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Nuvation Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Nuvation Bio over a specified time horizon. Remember, high Nuvation Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Nuvation Bio's market risk premium analysis include:
Beta 0.77 | Alpha (0.13) | Risk 5.16 | Sharpe Ratio (0.05) | Expected Return (0.26) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Nuvation |
Nuvation Bio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Nuvation Bio market risk premium is the additional return an investor will receive from holding Nuvation Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Nuvation Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Nuvation Bio's performance over market.| α | -0.13 | β | 0.77 |
Nuvation Bio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Nuvation Bio's Buy-and-hold return. Our buy-and-hold chart shows how Nuvation Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Nuvation Bio Market Price Analysis
Market price analysis indicators help investors to evaluate how Nuvation Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nuvation Bio shares will generate the highest return on investment. By understating and applying Nuvation Bio stock market price indicators, traders can identify Nuvation Bio position entry and exit signals to maximize returns.
Nuvation Bio Return and Market Media
The median price of Nuvation Bio for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 2.51 with a coefficient of variation of 12.85. The daily time series for the period is distributed with a sample standard deviation of 0.32, arithmetic mean of 2.46, and mean deviation of 0.26. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Innovent Announces Second New Drug Application of DOVBLERON was Approved by Chinas National Medical Products Administration | 01/03/2025 |
2 | Nuvation Bio Announces Expanded Access Program in the U.S. ... | 02/03/2025 |
3 | Bullish Nuvation Bio Insiders Loaded Up On US720.1k Of Stock | 02/12/2025 |
4 | Acquisition by Junyuan Wang of 1695700 shares of Nuvation Bio subject to Rule 16b-3 | 02/25/2025 |
5 | Acquisition by Stacy Markel of 500000 shares of Nuvation Bio at 1.94 subject to Rule 16b-3 | 02/28/2025 |
6 | Nuvation Bio Secures Up to 250 Million in Non-Dilutive Financings from Sagard Healthcare Partners | 03/03/2025 |
7 | How Has Nuvation Bio Positioned Itself in the Oncology Market | 03/04/2025 |
8 | Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | 03/06/2025 |
9 | Acquisition by Kathryn Falberg of 43000 shares of Nuvation Bio at 1.9526 subject to Rule 16b-3 | 03/07/2025 |
10 | Jones Trading sets 10 target for Nuvation Bio stock with Buy rating - Investing.com | 03/12/2025 |
About Nuvation Bio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Nuvation or other stocks. Alpha measures the amount that position in Nuvation Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Payables Turnover | 1.11 | 1.17 | Days Of Inventory On Hand | 9.3K | 8.3K |
Nuvation Bio Upcoming Company Events
As portrayed in its financial statements, the presentation of Nuvation Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nuvation Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Nuvation Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Nuvation Bio. Please utilize our Beneish M Score to check the likelihood of Nuvation Bio's management manipulating its earnings.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Nuvation Bio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Nuvation Bio Backtesting, Nuvation Bio Valuation, Nuvation Bio Correlation, Nuvation Bio Hype Analysis, Nuvation Bio Volatility, Nuvation Bio History and analyze Nuvation Bio Performance. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Nuvation Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.